- Bend Bulletin main site
- Bend Bulletin archives
- Terms of Use
- Privacy Policy
- Contact the Bulletin
- Comments/Questions?
Published daily in Bend, Oregon, by Western Communications, Inc. Copyright 2007.
June 8, 2006
The Food and Drug Administration this week approved the return of Tysabri, a promising drug used to treat multiple sclerosis. The drug was pulled from the market more than a year ago after three patients in clinical trials developed a rare and deadly disorder.
The agency said the drug should not....
